{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:36:56Z","timestamp":1794685016754,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872625"],"award-info":[{"award-number":["81872625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2017jcyjAX0275"],"award-info":[{"award-number":["cstc2017jcyjAX0275"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated the mechanisms underlying the preventive effect of dihydromyricetin (DHM) against liver fibrosis involving hepatic stellate cells (HSCs) and hepatic natural killer (NK) cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      )-induced liver fibrosis model was established in C57BL\/6 mice to study the antifibrotic effect of DHM based on serum biochemical parameters, histological and immunofluorescence stainings, and the expression of several fibrosis-related markers. Based on the immunoregulatory role of DHM, the effect of DHM on NK cell activation ex vivo was evaluated by flow cytometry. Then, we investigated whether DHM-induced autophagy was involved in HSCs inactivation using enzyme-linked immunosorbent assays, transmission electron microscopy, and western blot analysis. Thereafter, the role of DHM in NK cell-mediated killing was studied by in vitro coculture of NK cells and HSCs, with subsequent analysis by flow cytometry. Finally, the mechanism by which DHM regulates NK cells was studied by western blot analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DHM ameliorated liver fibrosis in C57BL\/6 mice, as characterized by decreased serum alanine transaminase and aspartate transaminase levels, decreased expressions of collagen I alpha 1 (CoL-1\u03b11), collagen I alpha 2 (CoL-1\u03b12), tissue inhibitor of metalloproteinases 1 (TIMP-1), \u03b1-smooth muscle actin (\u03b1-SMA) and desmin, as well as increased expression of matrix metalloproteinase 1 (MMP1). Interestingly, HSCs activation was significantly inhibited by DHM in vivo and in vitro. As expected, DHM also upregulated autophagy-related indicators in liver from CCl\n                      <jats:sub>4<\/jats:sub>\n                      -treated mice. DHM also prevented TGF-\u03b21-induced activation of HSCs in vitro by initiating autophagic flux. In contrast, the autophagy inhibitor 3-methyladenine markedly abolished the antifibrotic effect of DHM. Surprisingly, the frequency of activated intrahepatic NK cells was significantly elevated by DHM ex vivo. Furthermore, DHM enhanced NK cell-mediated killing of HSCs by increasing IFN-\u03b3 expression, which was abolished by an anti-IFN-\u03b3 neutralizing antibody. Mechanistically, DHM-induced IFN-\u03b3 expression was through AhR-NF-\u03baB\/STAT3 pathway in NK cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results demonstrated that DHM can ameliorate the progression of\u00a0liver\u00a0fibrosis and inhibition of HSCs activation by inducing autophagy and enhancing NK cell-mediated killing through the AhR-NF-\u03baB\/STAT3-IFN-\u03b3 signaling pathway, providing new insights into the preventive role of DHM in liver fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12986-021-00589-6","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T16:02:42Z","timestamp":1624118562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect"],"prefix":"10.1186","volume":"18","author":[{"given":"Xi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-2155","authenticated-orcid":false,"given":"Mantian","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"key":"589_CR1","doi-asserted-by":"crossref","unstructured":"Murag S, Ahmed A, Kim D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver 2020.","DOI":"10.5009\/gnl20127"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","volume":"62","author":"V Ratziu","year":"2015","unstructured":"Ratziu V, Goodman Z, Sanyal A. Current efforts and trends in the treatment of NASH. J Hepatol. 2015;62:S65-75.","journal-title":"J Hepatol"},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","volume":"28","author":"NE Sunny","year":"2017","unstructured":"Sunny NE, Bril F, Cusi K. Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol Metab. 2017;28:250\u201360.","journal-title":"Trends Endocrinol Metab"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/liv.12975","volume":"36","author":"F Salomone","year":"2016","unstructured":"Salomone F, Godos J, Zelber-Sagi S. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. Liver Int. 2016;36:5\u201320.","journal-title":"Liver Int"},{"key":"589_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.foodchem.2014.09.090","volume":"172","author":"L Ye","year":"2015","unstructured":"Ye L, Wang H, Duncan SE, Eigel WN, O\u2019Keefe SF. Antioxidant activities of Vine Tea (Ampelopsis grossedentata) extract and its major component dihydromyricetin in soybean oil and cooked ground beef. Food Chem. 2015;172:416\u201322.","journal-title":"Food Chem"},{"key":"589_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1745-4514.2009.00253.x","volume":"33","author":"J Gao","year":"2009","unstructured":"Gao J, Liu B, Ning Z, Zhao R, Zhang A, Wu Q. Characterization and antioxidant activity of flavonoid-rich extracts from leaves of Ampelopsis grossedentata. J Food Biochem. 2009;33:808\u201320.","journal-title":"J Food Biochem"},{"key":"589_CR9","doi-asserted-by":"publisher","first-page":"36184","DOI":"10.1038\/srep36184","volume":"6","author":"L Le","year":"2016","unstructured":"Le L, Jiang B, Wan W, Zhai W, Xu L, Hu K, Xiao P. Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity. Sci Rep. 2016;6:36184.","journal-title":"Sci Rep"},{"key":"589_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/ars.2017.7172","volume":"30","author":"X Zeng","year":"2019","unstructured":"Zeng X, Yang J, Hu O, Huang J, Ran L, Chen M, Zhang Y, Zhou X, Zhu J, Zhang Q, et al. Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling. Antioxid Redox Signal. 2019;30:163\u201383.","journal-title":"Antioxid Redox Signal"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","volume":"99","author":"S Chen","year":"2015","unstructured":"Chen S, Zhao X, Wan J, Ran L, Qin Y, Wang X, Gao Y, Shu F, Zhang Y, Liu P, et al. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res. 2015;99:74\u201381.","journal-title":"Pharmacol Res"},{"key":"589_CR12","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.3748\/wjg.v21.i18.5473","volume":"21","author":"J Xie","year":"2015","unstructured":"Xie J, Liu J, Chen TM, Lan Q, Zhang QY, Liu B, Dai D, Zhang WD, Hu LP, Zhu RZ. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice. World J Gastroenterol. 2015;21:5473\u201381.","journal-title":"World J Gastroenterol"},{"key":"589_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"589_CR14","doi-asserted-by":"crossref","unstructured":"Lucantoni F, Mart\u00ednez-Cerezuela A, Gruevska A, Moragrega \u00c1 B, V\u00edctor VM, Esplugues JV, Blas-Garc\u00eda A, Apostolova N. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? J Pathol 2021.","DOI":"10.1002\/path.5678"},{"key":"589_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/mnfr.201500016","volume":"59","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chen ML, Zhou Y, Yi L, Gao YX, Ran L, Chen SH, Zhang T, Zhou X, Zou D, et al. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Mol Nutr Food Res. 2015;59:1443\u201357.","journal-title":"Mol Nutr Food Res"},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/hep.26115","volume":"57","author":"Z Tian","year":"2013","unstructured":"Tian Z, Chen Y, Gao B. Natural killer cells in liver disease. Hepatology. 2013;57:1654\u201362.","journal-title":"Hepatology"},{"key":"589_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fimmu.2019.01192","volume":"10","author":"C Luci","year":"2019","unstructured":"Luci C, Vieira E, Perchet T, Gual P, Golub R. Natural killer cells and type 1 innate lymphoid cells are new actors in non-alcoholic fatty liver disease. Front Immunol. 2019;10:1192.","journal-title":"Front Immunol"},{"key":"589_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/liv.14307","volume":"40","author":"Y Fan","year":"2020","unstructured":"Fan Y, Zhang W, Wei H, Sun R, Tian Z, Chen Y. Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment. Liver Int. 2020;40:598\u2013608.","journal-title":"Liver Int"},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2019.05.023","volume":"71","author":"G Ravichandran","year":"2019","unstructured":"Ravichandran G, Neumann K, Berkhout LK, Weidemann S, Langeneckert AE, Schwinge D, Poch T, Huber S, Schiller B, Hess LU, et al. Interferon-\u03b3-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol. 2019;71:773\u201382.","journal-title":"J Hepatol"},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2019.03.012","volume":"71","author":"RS Wijaya","year":"2019","unstructured":"Wijaya RS, Read SA, Schibeci S, Eslam M, Azardaryany MK, El-Khobar K, van der Poorten D, Lin R, Yuen L, Lam V, et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol. 2019;71:252\u201364.","journal-title":"J Hepatol"},{"key":"589_CR21","doi-asserted-by":"crossref","unstructured":"Lee YJ, Kim J. Resveratrol Activates Natural Killer Cells through Akt- and mTORC2-Mediated c-Myb Upregulation. Int J Mol Sci. 2020; 21.","DOI":"10.3390\/ijms21249575"},{"key":"589_CR22","doi-asserted-by":"crossref","unstructured":"Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019; 11.","DOI":"10.3390\/nu11050946"},{"key":"589_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.intimp.2016.06.008","volume":"38","author":"S Wang","year":"2016","unstructured":"Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol. 2016;38:238\u201345.","journal-title":"Int Immunopharmacol"},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"106632","DOI":"10.1016\/j.intimp.2020.106632","volume":"85","author":"W Shi","year":"2020","unstructured":"Shi W, Wang Y, Zhang C, Jin H, Zeng Z, Wei L, Tian Y, Zhang D, Sun G. Isolation and purification of immune cells from the liver. Int Immunopharmacol. 2020;85:106632.","journal-title":"Int Immunopharmacol"},{"key":"589_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","volume":"30","author":"C Hellerbrand","year":"1999","unstructured":"Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol. 1999;30:77\u201387.","journal-title":"J Hepatol"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","volume":"88","author":"T Jiang","year":"2015","unstructured":"Jiang T, Harder B, Rojo de la Vega M, Wong PK, Chapman E, Zhang DD. p62 links autophagy and Nrf2 signaling. Free Radic Biol Med. 2015;88:199\u2013204.","journal-title":"Free Radic Biol Med"},{"key":"589_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313\u201326.","journal-title":"Cell"},{"key":"589_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.21419","volume":"44","author":"WI Jeong","year":"2006","unstructured":"Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. 2006;44:1441\u201351.","journal-title":"Hepatology"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.2010.211136","volume":"60","author":"N Muhanna","year":"2011","unstructured":"Muhanna N, Abu Tair L, Doron S, Amer J, Azzeh M, Mahamid M, Friedman S, Safadi R. Amelioration of hepatic fibrosis by NK cell activation. Gut. 2011;60:90\u20138.","journal-title":"Gut"},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.24190","volume":"53","author":"WI Jeong","year":"2011","unstructured":"Jeong WI, Park O, Suh YG, Byun JS, Park SY, Choi E, Kim JK, Ko H, Wang H, Miller AM, Gao B. Suppression of innate immunity (natural killer cell\/interferon-\u03b3) in the advanced stages of liver fibrosis in mice. Hepatology. 2011;53:1342\u201351.","journal-title":"Hepatology"},{"key":"589_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fphar.2018.00762","volume":"9","author":"Y Peng","year":"2018","unstructured":"Peng Y, Yang T, Huang K, Shen L, Tao Y, Liu C. Salvia miltiorrhiza ameliorates liver fibrosis by activating hepatic natural killer cells in vivo and in vitro. Front Pharmacol. 2018;9:762.","journal-title":"Front Pharmacol"},{"key":"589_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.4049\/jimmunol.1300497","volume":"192","author":"S Wagage","year":"2014","unstructured":"Wagage S, John B, Krock BL, Hall AO, Randall LM, Karp CL, Simon MC, Hunter CA. The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol. 2014;192:1661\u201370.","journal-title":"J Immunol"},{"key":"589_CR33","doi-asserted-by":"publisher","first-page":"5847040","DOI":"10.1155\/2019\/5847040","volume":"2019","author":"EG Assefa","year":"2019","unstructured":"Assefa EG, Yan Q, Gezahegn SB, Salissou MTM, He S, Wu N, Zuo X, Ying C. Role of resveratrol on indoxyl sulfate-induced endothelial hyperpermeability via aryl hydrocarbon receptor (AHR)\/Src-dependent pathway. Oxid Med Cell Longev. 2019;2019:5847040.","journal-title":"Oxid Med Cell Longev"},{"key":"589_CR34","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1289\/ehp.6322","volume":"111","author":"S Zhang","year":"2003","unstructured":"Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists\/antagonists: effects of structure and cell context. Environ Health Perspect. 2003;111:1877\u201382.","journal-title":"Environ Health Perspect"},{"key":"589_CR35","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3389\/fimmu.2018.01509","volume":"9","author":"L Yi","year":"2018","unstructured":"Yi L, Chen L, Guo X, Lu T, Wang H, Ji X, Zhang J, Ren Y, Pan P, Kinghorn AD, et al. A synthetic disaccharide derivative of diphyllin, TAARD, activates human natural killer cells to secrete interferon-gamma via toll-like receptor-mediated NF-\u03baB and STAT3 signaling pathways. Front Immunol. 2018;9:1509.","journal-title":"Front Immunol"},{"key":"589_CR36","doi-asserted-by":"publisher","first-page":"560905","DOI":"10.3389\/fphar.2020.560905","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Qian Q, Ying N, Lai J, Feng L, Zheng S, Jiang F, Song Q, Chai H, Dou X. Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice. Front Pharmacol. 2020;11:560905.","journal-title":"Front Pharmacol"},{"key":"589_CR37","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.18632\/oncotarget.2410","volume":"6","author":"H Zhu","year":"2015","unstructured":"Zhu H, Luo P, Fu Y, Wang J, Dai J, Shao J, Yang X, Chang L, Weng Q, Yang B. Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin. Oncotarget. 2015;6:3254.","journal-title":"Oncotarget"},{"key":"589_CR38","doi-asserted-by":"crossref","unstructured":"Xie K, He X, Chen K, Chen J, Sakao K, Hou DX. Antioxidant properties of a traditional vine tea, ampelopsis grossedentata. Antioxidants (Basel). 2019; 8.","DOI":"10.3390\/antiox8080295"},{"key":"589_CR39","first-page":"163","volume":"30","author":"X Zeng","year":"2019","unstructured":"Zeng X, Yang J, Hu O, Huang J, Ran L, Chen M, Zhang Y, Zhou X, Zhu J, Zhang Q. signaling r: Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling. Antioxidants. 2019;30:163\u201383.","journal-title":"Antioxidants"},{"key":"589_CR40","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/acer.14326","volume":"44","author":"J Silva","year":"2020","unstructured":"Silva J, Yu X, Moradian R, Folk C, Spatz MH, Kim P, Bhatti AA, Davies DL, Liang J. Dihydromyricetin protects the liver via changes in lipid metabolism and enhanced ethanol metabolism. Alcohol Clin Exp Res. 2020;44:1046\u201360.","journal-title":"Alcohol Clin Exp Res"},{"key":"589_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.alcohol.2020.10.002","volume":"91","author":"J Silva","year":"2020","unstructured":"Silva J, Spatz MH, Folk C, Chang A, Cadenas E, Liang J, Davies DL. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK\/Sirt-1\/PGC-1\u03b1 signaling axis. Alcohol. 2020;91:1\u20139.","journal-title":"Alcohol"},{"key":"589_CR42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.yjmcc.2011.06.010","volume":"51","author":"A Nemchenko","year":"2011","unstructured":"Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol. 2011;51:584\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"589_CR43","first-page":"357","volume":"4","author":"JS Carew","year":"2012","unstructured":"Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res. 2012;4:357\u201365.","journal-title":"Cancer Manag Res"},{"key":"589_CR44","doi-asserted-by":"publisher","first-page":"pe21","DOI":"10.1126\/scisignal.265pe21","volume":"2","author":"I Irrcher","year":"2009","unstructured":"Irrcher I, Park DS. Parkinson\u2019s disease: to live or die by autophagy. Sci Signal. 2009;2:pe21.","journal-title":"Sci Signal"},{"key":"589_CR45","doi-asserted-by":"publisher","first-page":"118666","DOI":"10.1016\/j.lfs.2020.118666","volume":"264","author":"W He","year":"2021","unstructured":"He W, Ni W, Zhao L, Wang X, Liu L, Fan Z. MicroRNA-125a\/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis. Life Sci. 2021;264:118666.","journal-title":"Life Sci"},{"key":"589_CR46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jhep.2020.04.044","volume":"73","author":"J Gao","year":"2020","unstructured":"Gao J, Wei B, de Assuncao TM, Liu Z, Hu X, Ibrahim S, Cooper SA, Cao S, Shah VH, Kostallari E. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol. 2020;73:1144\u201354.","journal-title":"J Hepatol"},{"key":"589_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10557-020-06968-0","volume":"34","author":"T Ni","year":"2020","unstructured":"Ni T, Lin N, Lu W, Sun Z, Lin H, Chi J, Guo H. Dihydromyricetin prevents diabetic cardiomyopathy via mir-34a suppression by activating autophagy. Cardiovasc Drugs Ther. 2020;34:291\u2013301.","journal-title":"Cardiovasc Drugs Ther"},{"key":"589_CR48","first-page":"372","volume":"20","author":"L Guo","year":"2020","unstructured":"Guo L, Tan K, Luo Q, Bai X. Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p\/PTEN signaling in diabetic nephropathy. Bosn J Basic Med Sci. 2020;20:372\u201380.","journal-title":"Bosn J Basic Med Sci"},{"key":"589_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.toxlet.2017.04.009","volume":"274","author":"P Qiu","year":"2017","unstructured":"Qiu P, Dong Y, Li B, Kang XJ, Gu C, Zhu T, Luo YY, Pang MX, Du WF, Ge WH. Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1\/Nrf2 pathway to alleviate ethanol-induced hepatic injury. Toxicol Lett. 2017;274:31\u201341.","journal-title":"Toxicol Lett"},{"key":"589_CR50","doi-asserted-by":"crossref","unstructured":"Triantafyllou E, Gudd CLC, Mawhin MA, Husbyn HC, Trovato FM, Siggins MK, O'Connor T, Kudo H, Mukherjee SK, Wendon JA, et al. PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury. J Clin Invest. 2020.","DOI":"10.1172\/JCI140196"},{"key":"589_CR51","doi-asserted-by":"crossref","unstructured":"Thomson PJ, Kafu L, Meng X, Snoeys J, De Bondt A, De Maeyer D, Wils H, Leclercq L, Vinken P, Naisbitt DJ. Drug-specific T-cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat. Allergy. 2020.","DOI":"10.1111\/all.14652"},{"key":"589_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-020-00363-9","volume":"5","author":"S Liao","year":"2020","unstructured":"Liao S, Zhan K, Gan L, Bai Y, Li J, Yuan G, Cai Y, Zhang A, He S, Mei Z. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients. Signal Transduct Target Ther. 2020;5:255.","journal-title":"Signal Transduct Target Ther"},{"key":"589_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2016.00019","volume":"7","author":"F Fasbender","year":"2016","unstructured":"Fasbender F, Widera A, Hengstler JG, Watzl C. Natural Killer Cells and Liver Fibrosis. Front Immunol. 2016;7:19.","journal-title":"Front Immunol"},{"key":"589_CR54","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","volume":"1832","author":"B Gao","year":"2013","unstructured":"Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta. 2013;1832:1061\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"589_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cellsig.2017.02.006","volume":"33","author":"H Jin","year":"2017","unstructured":"Jin H, Jia Y, Yao Z, Huang J, Hao M, Yao S, Lian N, Zhang F, Zhang C, Chen X, et al. Hepatic stellate cell interferes with NK cell regulation of fibrogenesis via curcumin induced senescence of hepatic stellate cell. Cell Signal. 2017;33:79\u201385.","journal-title":"Cell Signal"},{"key":"589_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513\u201328.","journal-title":"J Leukoc Biol"},{"key":"589_CR57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11427-018-9407-2","volume":"61","author":"H Peng","year":"2018","unstructured":"Peng H, Tian Z. NK cells in liver homeostasis and viral hepatitis. Sci China Life Sci. 2018;61:1477\u201385.","journal-title":"Sci China Life Sci"},{"key":"589_CR58","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3892\/ijmm.2017.3043","volume":"40","author":"JE Oh","year":"2017","unstructured":"Oh JE, Shim KY, Lee JI, Choi SI, Baik SK, Eom YW. 1-Methyl-L-tryptophan promotes the apoptosis of hepatic stellate cells arrested by interferon-\u03b3 by increasing the expression of IFN-\u03b3R\u03b2, IRF-1 and FAS. Int J Mol Med. 2017;40:576\u201382.","journal-title":"Int J Mol Med"},{"key":"589_CR59","doi-asserted-by":"publisher","first-page":"114093","DOI":"10.1016\/j.bcp.2020.114093","volume":"178","author":"KW Bock","year":"2020","unstructured":"Bock KW. Aryl hydrocarbon receptor (AHR) functions: balancing opposing processes including inflammatory reactions. Biochem Pharmacol. 2020;178:114093.","journal-title":"Biochem Pharmacol"},{"key":"589_CR60","doi-asserted-by":"publisher","first-page":"113620","DOI":"10.1016\/j.bcp.2019.08.022","volume":"169","author":"KW Bock","year":"2019","unstructured":"Bock KW. Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH). Biochem Pharmacol. 2019;169:113620.","journal-title":"Biochem Pharmacol"},{"key":"589_CR61","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/eji.201747289","volume":"48","author":"UY Moreno-Nieves","year":"2018","unstructured":"Moreno-Nieves UY, Mundy DC, Shin JH, Tam K, Sunwoo JB. The aryl hydrocarbon receptor modulates the function of human CD56(bright) NK cells. Eur J Immunol. 2018;48:771\u20136.","journal-title":"Eur J Immunol"},{"key":"589_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12974-019-1437-0","volume":"16","author":"M Ott","year":"2019","unstructured":"Ott M, Avenda\u00f1o-Guzm\u00e1n E, Ullrich E, Dreyer C, Strauss J, Harden M, Sch\u00f6n M, Sch\u00f6n MP, Bernhardt G, Stadelmann C, et al. Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer\/dendritic cell interaction to suppress CNS autoimmunity. J Neuroinflammation. 2019;16:49.","journal-title":"J Neuroinflammation"},{"key":"589_CR63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jcp.22233","volume":"225","author":"P Bachleda","year":"2010","unstructured":"Bachleda P, Vrzal R, Dvorak Z. Resveratrol enhances NK cell cytotoxicity: possible role for aryl hydrocarbon receptor. J Cell Physiol. 2010;225:289\u201390.","journal-title":"J Cell Physiol"},{"key":"589_CR64","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1039\/D0FO02622K","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Du P, Xie Q, Wang N, Li H, Smith EE, Li C, Liu F, Huo G, Li B. Protective effects of tryptophan-catabolizing Lactobacillus plantarum KLDS 1.0386 against dextran sodium sulfate-induced colitis in mice. Food Funct. 2020;11:10736\u201347.","journal-title":"Food Funct"},{"key":"589_CR65","doi-asserted-by":"publisher","first-page":"112288","DOI":"10.1016\/j.yexcr.2020.112288","volume":"396","author":"J Xiong","year":"2020","unstructured":"Xiong J, Zhang X, Zhang Y, Wu B, Fang L, Wang N, Yi H, Chang N, Chen L, Zhang J. Aryl hydrocarbon receptor mediates Jak2\/STAT3 signaling for non-small cell lung cancer stem cell maintenance. Exp Cell Res. 2020;396:112288.","journal-title":"Exp Cell Res"},{"key":"589_CR66","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1084\/jem.20090560","volume":"206","author":"A Kimura","year":"2009","unstructured":"Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K, Fujii-Kuriyama Y, Kishimoto T. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med. 2009;206:2027\u201335.","journal-title":"J Exp Med"},{"key":"589_CR67","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jdermsci.2020.10.004","volume":"100","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang X, Zhang J, Luo Y, Xu B, Ling S, Zhang Y, Li W, Yao X. Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation. J Dermatol Sci. 2020;100:192\u2013200.","journal-title":"J Dermatol Sci"},{"key":"589_CR68","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.4049\/jimmunol.1302600","volume":"193","author":"Y Deng","year":"2014","unstructured":"Deng Y, Chu J, Ren Y, Fan Z, Ji X, Mundy-Bosse B, Yuan S, Hughes T, Zhang J, Cheema B, et al. The natural product phyllanthusmin C enhances IFN-\u03b3 production by human NK cells through upregulation of TLR-mediated NF-\u03baB signaling. J Immunol. 2014;193:2994\u20133002.","journal-title":"J Immunol"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-021-00589-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T16:12:11Z","timestamp":1624119131000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-021-00589-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s12986-021-00589-6","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments were supervised by the Animal Care and Use Committee of the Third Military Medical University (Chongqing, China; Approval SYXC-2015-00169).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}